Search Results - "Beuvery, E.C"

Refine Results
  1. 1

    practical approach for exploration and modeling of the design space of a bacterial vaccine cultivation process by Streefland, M, Van Herpen, P.F.G, Van de Waterbeemd, B, Van der Pol, L.A, Beuvery, E.C, Tramper, J, Martens, D.E, Toft, M

    Published in Biotechnology and bioengineering (15-10-2009)
    “…A licensed pharmaceutical process is required to be executed within the validated ranges throughout the lifetime of product manufacturing. Changes to the…”
    Get full text
    Journal Article
  2. 2

    Determination of amino acids using o-phthalaldehyde-2-mercaptoethanol derivatization effect of reaction conditions by Dorresteijn, R.C., Berwald, L.G., Zomer, G., de Gooijer, C.D., Wieten, G., Beuvery, E.C.

    Published in Journal of Chromatography A (16-02-1996)
    “…This paper presents a systematic approach to determine the optimal reaction conditions, with respect to accuracy and sensitivity, of the quantitative…”
    Get full text
    Journal Article
  3. 3

    Modeling Neisseria meningitidis metabolism: from genome to metabolic fluxes by Baart, Gino J E, Zomer, Bert, de Haan, Alex, van der Pol, Leo A, Beuvery, E Coen, Tramper, Johannes, Martens, Dirk E

    Published in Genome Biology (06-07-2007)
    “…Neisseria meningitidis is a human pathogen that can infect diverse sites within the human host. The major diseases caused by N. meningitidis are responsible…”
    Get full text
    Journal Article
  4. 4

    Gene-expression-based quality scores indicate optimal harvest point in Bordetella pertussis cultivation for vaccine production by van de Waterbeemd, Bas, Streefland, Mathieu, Pennings, Jeroen, van der Pol, Leo, Beuvery, Coen, Tramper, Johannes, Martens, Dirk

    Published in Biotechnology and bioengineering (01-08-2009)
    “…The evolution of vaccine product quality during batch cultivation of Bordetella pertussis, the causative agent of whooping cough, was investigated with the…”
    Get full text
    Journal Article
  5. 5

    Modeling Neisseria meningitidis B metabolism at different specific growth rates by Baart, Gino J.E, Willemsen, Marieke, Khatami, Elnaz, de Haan, Alex, Zomer, Bert, Beuvery, E. Coen, Tramper, Johannes, Martens, Dirk E

    Published in Biotechnology and bioengineering (01-12-2008)
    “…Neisseria meningitidis is a human pathogen that can infect diverse sites within the human host. The major diseases caused by N. meningitidis are responsible…”
    Get full text
    Journal Article
  6. 6

    Death rate in a small air-lift loop reactor of vero cells grown on solid microcarriers and in macroporous microcarriers by MARTENS, D. E, NOLLEN, E. A. A, HARDEVELD, M, VAN DER VELDEN-DE GROOT, C. A. M, DE GOOIJER, C. D, BEUVERY, E. C, TRAMPER, J

    Published in Cytotechnology (Dordrecht) (1997)
    “…The death rate of Vero cells grown on Cytodex-3 microcarrierswas studied as a function of the gas flow rate in a smallair-lift loop reactor. The death rate may…”
    Get full text
    Journal Article
  7. 7

    Improving the cellular pertussis vaccine: Increased potency and consistency by Thalen, Marcel, van der Ark, Arno, van den IJssel, Jan, van Straaten, Ineke, Jansen, Dennis, Beuvery, Coen, Martens, Dirk, Tramper, Johannes

    Published in Vaccine (30-01-2008)
    “…Summary Although Europe, Canada and the US have switched from cellular to acellular pertussis vaccines, most developing countries will continue to use the more…”
    Get full text
    Journal Article
  8. 8

    PAT for vaccines: The first stage of PAT implementation for development of a well-defined whole-cell vaccine against whooping cough disease by Streefland, Mathieu, van de Waterbeemd, Bas, Happé, Hester, van der Pol, Leo A, Beuvery, E. Coen, Tramper, Johannes, Martens, Dirk E

    Published in Vaccine (20-04-2007)
    “…Abstract Since variation in process time and process output is commonly accepted to be inevitable for biological processes, application of Process Analytical…”
    Get full text
    Journal Article Conference Proceeding
  9. 9

    Expression of phosphofructokinase in Neisseria meningitidis by Baart, Gino J. E, Langenhof, Marc, van de Waterbeemd, Bas, Hamstra, Hendrik-Jan, Zomer, Bert, van der Pol, Leo A, Beuvery, E. C, Tramper, Johannes, Martens, Dirk E

    “…1 Netherlands Vaccine Institute (NVI), Unit Research and Development, PO Box 457, 3720 AL Bilthoven, The Netherlands 2 Wageningen University, Food and…”
    Get full text
    Journal Article
  10. 10

    Scale-up for bulk production of vaccine against meningococcal disease by Baart, Gino J.E, de Jong, Govert, Philippi, Marvin, Riet, Klaas van’t, van der Pol, Leo A, Beuvery, E. Coen, Tramper, Johannes, Martens, Dirk E

    Published in Vaccine (21-08-2007)
    “…Abstract At the Netherlands Vaccine Institute (NVI) a vaccine against Neisseria meningitidis serogroup B organisms based on different porA subtypes contained…”
    Get full text
    Journal Article
  11. 11

    Evaluation of a critical process parameter: Oxygen limitation during cultivation has a fully reversible effect on gene expression of Bordetella pertussis by Streefland, Mathieu, van de Waterbeemd, Bas, Kint, Joeri, van der Pol, Leo A, Beuvery, E. Coen, Tramper, Johannes, Martens, Dirk E

    Published in Biotechnology and bioengineering (2009)
    “…Modern (bio)pharmaceutical process development requires thorough investigation of all process parameters that are critical to product quality. The impact of a…”
    Get full text
    Journal Article
  12. 12

    Effect of relevant culture parameters on Pertussis Toxin expression by Bordetella pertussis by Thalen, Marcel, Venema, Marian, van den IJssel, Jan, Berwald, Luc, Beuvery, Coen, Martens, Dirk, Tramper, Johannes

    Published in Biologicals (01-09-2006)
    “…Whooping cough vaccines are produced using different ranges of cultivation conditions and medium compositions, which are known to influence growth rate,…”
    Get full text
    Journal Article
  13. 13

    Fed-batch cultivation of Bordetella pertussis: Metabolism and Pertussis Toxin production by Thalen, Marcel, Venema, Marian, Dekker, Anita, Berwald, Luc, van den IJssel, Jan, Zomer, Bert, Beuvery, Coen, Martens, Dirk, Tramper, Johannes

    Published in Biologicals (01-12-2006)
    “…The production of acellular pertussis in comparison with whole cell pertussis vaccines demands 5–25 times the amount of Bordetella pertussis' virulence…”
    Get full text
    Journal Article
  14. 14

    Dual-substrate utilization by Bordetella pertussis by NEELEMAN, R, JOERINK, M, BEUVERY, C, VAN BOXTEL, T

    Published in Applied microbiology and biotechnology (01-11-2001)
    “…To improve the cultivation of Bordetella pertussis and take advantage of the newest techniques in monitoring and control, a quantitative description of…”
    Get full text
    Journal Article
  15. 15

    Manufacturing Vaccines: An Illustration of Using PAT Tools for Controlling the Cultivation of Bordetella pertussis by van Sprang, Eric N. M., Streefland, Mathieu, Ramaker, Henk-Jan, van der Pol, Leo A., Beuvery, E. Coen, Smilde, Age. K.

    Published in Quality engineering (29-10-2007)
    “…An illustration of the operational consistency of the upstream part of a biopharmaceutical process is given. For this purpose four batch cultivations of…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Comparison of four bifunctional reagents for coupling peptides to proteins and the effect of the three moieties on the immunogenicity of the conjugates by Peeters, J M, Hazendonk, T G, Beuvery, E C, Tesser, G I

    Published in Journal of immunological methods (02-06-1989)
    “…Peptide-carrier conjugates are widely used to raise antipeptide antibodies. In a model system using angiotensin and tetanus toxoid as the peptide and the…”
    Get more information
    Journal Article
  18. 18
  19. 19

    On-line estimation of the biomass activity during animal-cell cultivations by Dorresteijn, R.C, Harbrink Numan, K, Gooijer, C.D. de, Tramper, J, Beuvery, E.C

    Published in Biotechnology and bioengineering (20-07-1996)
    “…A software sensor was developed to determine the volumetric biomass activity of animal cell cultivations on-line. It was based on the on-line estimation of the…”
    Get full text
    Journal Article
  20. 20

    A New WHO International Reference Reagent for Use in Potency Assays of Inactivated Poliomyelitis Vaccine by Wood, D.J., Heath, A.B., Kersten, G.F.A., Hazendonk, T., Lantinga, M., Beuvery, E.C.

    Published in Biologicals (01-03-1997)
    “…Assays of the potency of inactivated poliovirus vaccine require the use of an appropriate reference reagent. Preparation 91/574 was shown by international…”
    Get full text
    Journal Article